Clinical Trial Update: A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

View source ↗

Summary

A completed non-interventional observational study sponsored by AstraZeneca to investigate the current situation of asthma-COPD overlap syndrome in adults over …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma-copd Overlap Syndrome

Snippet

Sponsor: AstraZeneca | Conditions: Asthma-COPD Overlap Syndrome | Status: COMPLETED